» Articles » PMID: 32858990

Diffusion-Weighted MRI and Diffusion Kurtosis Imaging to Detect RAS Mutation in Colorectal Liver Metastasis

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2020 Aug 30
PMID 32858990
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To detect RAS mutation in colorectal liver metastasis by Diffusion-Weighted Magnetic Resonance Imaging (DWI-MRI) - and Diffusion Kurtosis imaging (DKI)-derived parameters.

Methods: In total, 106 liver metastasis (60 metastases with RAS mutation) in 52 patients were included in this retrospective study. Diffusion and perfusion parameters were derived by DWI (apparent diffusion coefficient (ADC), basal signal (S0), pseudo-diffusion coefficient (DP), perfusion fraction (FP) and tissue diffusivity (DT)) and DKI data (mean of diffusion coefficient (MD) and mean of diffusional Kurtosis (MK)). Wilcoxon-Mann-Whitney U tests for non-parametric variables and receiver operating characteristic (ROC) analyses were calculated with area under ROC curve (AUC). Moreover, pattern recognition approaches (linear classifier, support vector machine, k-nearest neighbours, decision tree), with features selection methods and a leave-one-out cross validation approach, were considered.

Results: A significant discrimination between the group with RAS mutation and the group without RAS mutation was obtained by the standard deviation value of MK (MK STD), by the mean value of MD, and by that of FP. The best results were reached by MK STD with an AUC of 0.80 (sensitivity of 72%, specificity of 85%, accuracy of 79%) using a cut-off of 203.90 × 10, and by the mean value of MD with AUC of 0.80 (sensitivity of 84%, specificity of 73%, accuracy of 77%) using a cut-off of 1694.30 mm/s × 10. Considering all extracted features or the predictors obtained by the features selection method (the mean value of S0, the standard deviation value of MK, FP and of DT), the tested pattern recognition approaches did not determine an increase in diagnostic accuracy to detect RAS mutation (AUC of 0.73 and 0.69, respectively).

Conclusions: Diffusion-Weighted imaging and Diffusion Kurtosis imaging could be used to detect the RAS mutation in liver metastasis. The standard deviation value of MK and the mean value of MD were the more accurate parameters in the RAS mutation detection, with an AUC of 0.80.

Citing Articles

Improved treatment of colorectal liver metastases by early response evaluation and regimen adjustment: a prospective study of clinical functional MR-based modeling.

Li W, Zhang H, Gong Z, Li Y, Chen Z, Zhu X Cancer Biol Med. 2025; 22(2).

PMID: 39985133 PMC: 11899590. DOI: 10.20892/j.issn.2095-3941.2024.0389.


Image Analysis as tool for Predicting Colorectal Cancer Molecular Alterations: A Scoping Review.

Mohammadpour S, Emami H, Rabiei R, Hosseini A, Moghaddasi H, Faeghi F Mol Imaging Radionucl Ther. 2025; 34(1):10-25.

PMID: 39917985 PMC: 11827529. DOI: 10.4274/mirt.galenos.2024.86402.


Differentiation of early-stage endometrial carcinoma from benign endometrial lesions: a comparative study of six diffusion models.

Bi Q, Deng Y, Xu N, Wu S, Zhang H, Huang Y Quant Imaging Med Surg. 2025; 15(1):121-134.

PMID: 39839005 PMC: 11744118. DOI: 10.21037/qims-24-896.


Risk Assessment and Radiomics Analysis in Magnetic Resonance Imaging of Pancreatic Intraductal Papillary Mucinous Neoplasms (IPMN).

Flammia F, Fusco R, Triggiani S, Pellegrino G, Reginelli A, Simonetti I Cancer Control. 2024; 31:10732748241263644.

PMID: 39293798 PMC: 11412216. DOI: 10.1177/10732748241263644.


Radiomics and machine learning analysis of liver magnetic resonance imaging for prediction and early detection of tumor response in colorectal liver metastases.

Yoon S, Kim Y, Jeon J, Ahn S, Choi S Korean J Clin Oncol. 2024; 20(1):27-35.

PMID: 38988016 PMC: 11261177. DOI: 10.14216/kjco.24005.


References
1.
Jo S, Kim S . Association between oncogenic RAS mutation and radiologic-pathologic findings in patients with primary rectal cancer. Quant Imaging Med Surg. 2019; 9(2):238-246. PMC: 6414762. DOI: 10.21037/qims.2018.12.10. View

2.
Xia W, Chen Y, Zhang R, Yan Z, Zhou X, Zhang B . Radiogenomics of hepatocellular carcinoma: multiregion analysis-based identification of prognostic imaging biomarkers by integrating gene data-a preliminary study. Phys Med Biol. 2018; 63(3):035044. DOI: 10.1088/1361-6560/aaa609. View

3.
Le Bihan D, Breton E, lAllemand D, Grenier P, Cabanis E, LAVAL-JEANTET M . MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology. 1986; 161(2):401-7. DOI: 10.1148/radiology.161.2.3763909. View

4.
Karapetis C, Khambata-Ford S, Jonker D, OCallaghan C, Tu D, Tebbutt N . K-ras mutations and benefit from cetuximab in advanced colorectal cancer. N Engl J Med. 2008; 359(17):1757-65. DOI: 10.1056/NEJMoa0804385. View

5.
Luciani A, Vignaud A, Cavet M, Tran Van Nhieu J, Mallat A, Ruel L . Liver cirrhosis: intravoxel incoherent motion MR imaging--pilot study. Radiology. 2008; 249(3):891-9. DOI: 10.1148/radiol.2493080080. View